231 related articles for article (PubMed ID: 17927890)
1. [Clinical research advancement on male breast cancer].
Xue Y; Guo XT; Liu WC
Ai Zheng; 2007 Oct; 26(10):1148-52. PubMed ID: 17927890
[TBL] [Abstract][Full Text] [Related]
2. Male breast cancer.
Gómez-Raposo C; Zambrana Tévar F; Sereno Moyano M; López Gómez M; Casado E
Cancer Treat Rev; 2010 Oct; 36(6):451-7. PubMed ID: 20193984
[TBL] [Abstract][Full Text] [Related]
3. Tumor angiogenesis predicts clinical outcome of node-positive breast cancer patients treated with adjuvant hormone therapy or chemotherapy.
Gasparini G; Barbareschi M; Boracchi P; Verderio P; Caffo O; Meli S; Dalla Palma P; Marubini E; Bevilacqua P
Cancer J Sci Am; 1995; 1(2):131-41. PubMed ID: 9166466
[TBL] [Abstract][Full Text] [Related]
4. Male breast cancer: a multicentric study.
Culell P; Solernou L; Tarazona J; Roma J; Martí E; Miguel A; Buxó J; Yanguas C; Badal JM
Breast J; 2007; 13(2):213-5. PubMed ID: 17319872
[No Abstract] [Full Text] [Related]
5. Male breast cancer: a survey at the Helsinki University Central Hospital during 1981-2006.
Liukkonen S; Saarto T; Mäenpää H; Sjöström-Mattson J
Acta Oncol; 2010 Apr; 49(3):322-7. PubMed ID: 20397767
[TBL] [Abstract][Full Text] [Related]
6. Synchronous bilateral breast cancer in an aged male patient.
Yaman E; Ozturk B; Coskun U; Buyukberber S; Kaya AO; Yildiz R; Benekli M
Onkologie; 2010; 33(5):255-8. PubMed ID: 20502060
[TBL] [Abstract][Full Text] [Related]
7. [Diagnosis and prognosis study of breast carcinoma with micropapillary component].
Chen L; Fan Y; Lang RG; Guo XJ; Sun YL; Fu L
Zhonghua Bing Li Xue Za Zhi; 2007 Apr; 36(4):228-32. PubMed ID: 17706112
[TBL] [Abstract][Full Text] [Related]
8. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
Gasparini G; Barbareschi M; Doglioni C; Palma PD; Mauri FA; Boracchi P; Bevilacqua P; Caffo O; Morelli L; Verderio P
Clin Cancer Res; 1995 Feb; 1(2):189-98. PubMed ID: 9815973
[TBL] [Abstract][Full Text] [Related]
9. [Clinical analysis of resectable breast cancer: a report of 6 263 cases].
Yang MT; Rong TH; Huang ZF; Zeng CG; Long H; Fu JH; Lin P; Wang X; Wang SY; Wang X; Tang J
Ai Zheng; 2005 Mar; 24(3):327-31. PubMed ID: 15757535
[TBL] [Abstract][Full Text] [Related]
10. [Three men with breast cancer].
Bergs EA; Tanis PJ; Steller EP
Ned Tijdschr Geneeskd; 2005 Mar; 149(10):534-7. PubMed ID: 15782690
[TBL] [Abstract][Full Text] [Related]
11. Male breast cancer: a case report and review of the literature.
Petrocca S; La Torre M; Cosenza G; Bocchetti T; Cavallini M; Di Stefano D; Sammartino F; Ziparo V
Chir Ital; 2005; 57(3):365-71. PubMed ID: 16231827
[TBL] [Abstract][Full Text] [Related]
12. Clinical relevance of vascular endothelial growth factor and thymidine phosphorylase in patients with node-positive breast cancer treated with either adjuvant chemotherapy or hormone therapy.
Gasparini G; Toi M; Miceli R; Vermeulen PB; Dittadi R; Biganzoli E; Morabito A; Fanelli M; Gatti C; Suzuki H; Tominaga T; Dirix LY; Gion M
Cancer J Sci Am; 1999; 5(2):101-11. PubMed ID: 10198732
[TBL] [Abstract][Full Text] [Related]
13. [Prospective randomized trial on the efficacy of adjuvant endocrine therapy for ER-positive breast cancer patients after radical mastectomy].
Jiang Z; Song S; Liu X
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):420-2. PubMed ID: 11810777
[TBL] [Abstract][Full Text] [Related]
14. Tamoxifen versus control after adjuvant, risk-adapted chemotherapy in postmenopausal, receptor-negative patients with breast cancer: a randomized trial (GABG-IV D-93)--the German Adjuvant Breast Cancer Group.
Kaufmann M; Graf E; Jonat W; Eiermann W; Geberth M; Albert US; Gademann G; Conrad B; Stahl K; von Minckwitz G; Schumacher M;
J Clin Oncol; 2005 Nov; 23(31):7842-8. PubMed ID: 16258087
[TBL] [Abstract][Full Text] [Related]
15. Male breast cancer.
Fentiman IS; Fourquet A; Hortobagyi GN
Lancet; 2006 Feb; 367(9510):595-604. PubMed ID: 16488803
[TBL] [Abstract][Full Text] [Related]
16. Male breast cancer.
Reis LO; Dias FG; Castro MA; Ferreira U
Aging Male; 2011 Jun; 14(2):99-109. PubMed ID: 21204612
[TBL] [Abstract][Full Text] [Related]
17. The nature of tamoxifen action in the control of female breast cancer.
Kodama M; Kodama T
In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224
[TBL] [Abstract][Full Text] [Related]
18. Optimal management of ductal carcinoma in situ of the breast.
Sakorafas GH; Farley DR
Surg Oncol; 2003 Dec; 12(4):221-40. PubMed ID: 14998563
[TBL] [Abstract][Full Text] [Related]
19. Tamoxifen in ductal carcinoma in situ.
Daly MB
Semin Oncol; 2006 Dec; 33(6):647-9. PubMed ID: 17145343
[TBL] [Abstract][Full Text] [Related]
20. Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.
Johansen J; Overgaard J; Overgaard M
Acta Oncol; 2007; 46(4):525-33. PubMed ID: 17497320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
